The mention of non disclosures and speaking with a

The mention of non disclosures and speaking with a number of interested parties makes it obvious. My assumption is for P and markers being met that initiates a partnership. Time will tell. Competition will raise that asking price and the price of the stock. Even more important, it should finance the other trials and potentially accelerate their speed toward FDA approvals and saving lives.